Calidi Biotherapeutics (CLDI) Other Non-Current Liabilities (2021 - 2026)
Calidi Biotherapeutics' Other Non-Current Liabilities was $63,000 in Q2 2026, down 34.4% from $96,000 a year earlier.
Powered by 
Analysis
Calidi Biotherapeutics (CLDI) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends
At the end of FY2025, Other Non-Current Liabilities at Calidi Biotherapeutics came in at $107,000, down 10.1% from FY2024.
- Other Non-Current Liabilities has now declined for four consecutive years, with a four-year compound annual growth rate of -65.4% (FY2021 to FY2025).
- In earlier years, Other Non-Current Liabilities was $119,000 in FY2024 (-80.9%), $623,000 in FY2023 (-16.4%), $745,000 in FY2022 (-90.0%) and $7.47 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Other Non-Current Liabilities in data going back to Q4 2021.
- Compared with a year earlier, Other Non-Current Liabilities was higher in 1 of the last seven quarters, with an average decline of 53.6%.
- The best year-over-year quarter for Other Non-Current Liabilities over five years was Q3 2025 (growth of 14.1%); the worst was Q3 2024 (a decline of 94.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn |
| 10 | Calidi Biotherapeutics | 906,381.60 | -24.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 63,000.00 |
| Dec 31, 2025 | 107,000.00 |
| Sep 30, 2025 | 186,000.00 |
| Jun 30, 2025 | 96,000.00 |
| Mar 31, 2025 | 81,000.00 |
| Dec 31, 2024 | 119,000.00 |
| Sep 30, 2024 | 163,000.00 |
| Jun 30, 2024 | 524,000.00 |
| Mar 31, 2024 | 647,000.00 |
| Dec 31, 2023 | 623,000.00 |
| Sep 30, 2023 | 3.46 Mn |
| Jun 30, 2023 | 1.94 Mn |
| Mar 31, 2023 | 656,500.00 |
| Dec 31, 2022 | 745,000.00 |
| Sep 30, 2022 | 8.94 Mn |
| Jun 30, 2022 | 9.40 Mn |
| Mar 31, 2022 | 13.42 Mn |
| Dec 31, 2021 | 7.47 Mn |
API Access
Calidi Biotherapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=CLDI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "CLDI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=CLDI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();